EVP, Chief Reg. & Quality Off.
Thu, Jul 2, 2026
Jul 2
1,500 shares @ $524.99
Decreased holdings by -3.20%
15th largest trade (out of 116)
Planned (10b5-1)
“Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 08/21/2025.”Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
9% win rate · -15.6% median edge vs SPY (53 trades, 90-day)
Price 19% above 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).